Neuberger Berman Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Sell
6,895
-175,069
-96% -$6.55M ﹤0.01% 1866
2025
Q4
$6.33M Buy
181,964
+131,771
+263% +$10.3M ﹤0.01% 919
2025
Q3
$4.17M Sell
50,193
-14,686
-23% -$1.06M ﹤0.01% 1006
2025
Q2
$4.76M Buy
64,879
+8,959
+16% +$650K ﹤0.01% 974
2025
Q1
$6.39M Sell
55,920
-72,749
-57% -$4.43M 0.01% 883
2024
Q4
$6.48M Buy
128,669
+12,332
+11% +$646K 0.01% 896
2024
Q3
$5.38M Buy
+116,337
New +$4.13M ﹤0.01% 929
2017
Q4
Sell
-39,891
Closed -$770K 1764
2017
Q3
$770K Sell
39,891
-3,249
-8% -$48.4K ﹤0.01% 1212
2017
Q2
$509K Sell
43,140
-78,706
-65% -$855K ﹤0.01% 1311
2017
Q1
$1.33M Buy
121,846
+22,454
+23% +$197K ﹤0.01% 1084
2016
Q4
$722K Buy
+99,392
New +$779K ﹤0.01% 1206

Other funds holding CORT